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Abstract
Background: The current study aimed to further our understanding of second opinions among medical oncology
patients by examining the proportion of patients who sought a second opinion about their cancer treatment, and
why.
Methods: The study was conducted between 2013 and 2015 in three medical oncology clinics located in public
hospitals in Australia: in metropolitan New South Wales, metropolitan Queensland, and in Tasmania.
Those patients who provide written informed consent were asked to complete a brief paper and pencil survey in the
clinic containing questions on sociodemographic, disease and treatment characteristics. Approximately 1month later,
participants were mailed a second paper and pencil survey which contained questions about whether they had sought
a second opinion and their motivation for doing so. Non-responders were followed up by letter at 3 and 6 weeks.
Results: Of 823 patients screened for eligibility, 698 eligible patients, 612 provided consent.
Of those who consented, 355 completed both the initial survey and the second survey and were included in the
analyses. Of the 57 patients who sought a second opinion, the most frequent reasons given for doing so were the need
for reassurance (49.1%) and the need to consider the range of treatment options (41.8%).
Of the 297 (83.6%) participants who did not seek a second opinion, the main reason was confidence in the first doctor
(88.7%). Only 3.1% patients did not know that they could ask for a second opinion. Occasionally the doctor will initiate
the referral for a second opinion.
Conclusions: Our study suggests that a minority of cancer patients seek a second opinion at some phase during their
care. Most did so for reassurance or to ensure that they had covered all of the treatment options and not because of
discomfort or distrust of their treating doctor.
Few patients reported a lack of awareness of second opinions. This suggests that second opinions form part of a
patient-centred approach to information provision about care options. Whether the second opinion improves the
quality of care or indeed outcomes has been difficult to demonstrate.
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Background
A second opinion is defined as seeking an independent
opinion on either diagnosis or treatment by an expert in
the same field as the specialist who gave the initial opin-
ion [1]. A second opinion can be sought by the patient,
a specialist, a health institution or insurer.
In contrast to the large literature on doctor-initiated
second opinions, comparatively less attention has been
given to patient-initiated second opinions. This is sur-
prising as the principles of patient-centred care empha-
sise the need to inform patients about their options and
to provide care that is responsive to their needs, values
and preferences [2]. Therefore, ensuring that patients
know that they have the right to seek a second opinion,
and supporting patients to seek a second opinion where
they express a preference for this, aligns with the ethos
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of patient-centred care. Consumers have also recom-
mended that information on the ‘possibility of a second
opinion’ be considered an indicator of patient-centred
care [3].
A review of 20 quantitative studies of patients with
cancer seeking second opinions found that the rates of
seeking second opinions ranged between 1 and 88% [1].
Patients with higher levels of education were more likely
to seek second opinions than other patients [1]. Another
review of seven studies of patient-initiated second opin-
ions found that while most second opinions confirmed
the initial diagnosis, between 10 and 60% of second
opinions resulted to a change in diagnosis, management
or prognosis [4].
The majority of past studies on second opinions have
been conducted in the USA [1]. Given differences in
health care systems, results are unlikely to be
generalizable to countries such as Australia, which has a
universal health care system with oncology care freely
available via public hospitals and primary care. One
prior Australian study which examined the prevalence of
patient-initiated second opinions among oncology pa-
tients in Australia was a single institution study con-
ducted between 2006 to 2008 by Tattersall et al. [5].
They found that 6.5% of 1892 newly diagnosed oncology
patients sought a second opinion. The most frequent
reasons given for seeking a second opinion were to seek
more information or just gain reassurance about the
diagnosis and treatment. A second smaller Australian
single institution study found that 33% of 52 patients
sought a second medical opinion, most commonly be-
cause of communication issues with their first doctor
[6].
The current study was part of larger study investigat-
ing the role of individual patient, social support and
treatment centre variables in the psychosocial outcomes
of cancer patients form the patient, multidisciplinary
team and administrative perspective. A literature review
identified the variables and the resulting patient ques-
tionnaires were pilot tested on a patient group. We
aimed to further our understanding of second opinions
among Australian medical oncology patients by examin-
ing the proportion of patients who sought a second
opinion about their cancer treatment, and the reasons
for seeking or not seeking a second opinion.
The topics align with published papers on second
opinion and with the study clinicians’ experiences.
Methods
The study was conducted in three medical oncology
clinics located in public hospitals in Australia: one was
located in metropolitan New South Wales, another in
metropolitan Queensland, and the other in Tasmania.
Approval was gained from University of Newcastle
Human Research Ethics Committee as well as from each
institution. The study was conducted between 2013 and
2015.
Patients were eligible if they were aged 18 or older,
had a confirmed diagnosis of cancer and were attending
a participating clinic. Those who were attending the
clinic for the first time or who were too unwell to
complete the survey were excluded.
A research assistant provided written information
about the study and sought informed consent from eli-
gible patients who presented to participating clinics.
Those who consented were asked to complete a brief
paper and pencil survey in the clinic containing ques-
tions on sociodemographic, disease and treatment char-
acteristics. Approximately 1 month later, participants
were mailed a second paper and pencil survey which
contained questions about whether they had sought a
second opinion and their motivation for doing so. Non-
responders were followed up by letter at 3 and 6 weeks.
Measures
Demographic characteristics
Age, gender, education, marital status, living situation,
employment status, private health insurance status, con-
cession card status was sought by patient self-report.
Reasons for seeking a second opinion
Respondents were asked whether they had ever con-
sulted another doctor for a second opinion about their
cancer treatment. Those who responded yes were asked,
“Why did you seek a second opinion?” Response options
included: My family and/or friends asked me to; I
needed more opportunity to consider and discuss my
options, I needed to be reassured about the best option;
I didn’t understand the information or treatment choices
the first doctor gave me; I did not trust or agree with
the first doctor’s opinion; The first doctor didn’t seem to
understand my situation or concerns; I did not feel com-
fortable with my first doctor; or other.
Reasons for not seeking a second opinion
Those who indicated that they had not sought a second
opinion were asked why. Response options included: I
was confident in my first doctor’s opinion; I didn’t want
to upset/ annoy my doctor; I didn’t know which doctor
to see; I felt rushed into treatment; I just wanted to start
treatment as soon as possible; I didn’t have enough time;
I didn’t have enough money; I didn’t know I could get a
second opinion; or “other”.
Statistical methods
Statistical analyses were programmed using SAS v9.4
(SAS Institute, Cary, North Carolina, USA).
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Characteristics of the sample are presented as frequen-
cies and percentages for categorical demographic vari-
ables and means (standard deviation) and medians
(range) for continuous variables.
The results of questions are presented as frequencies
and as percentages with 95% confidence intervals esti-
mated by accounting for clustering by treatment center
and using the delete-1 jackknife method.
Results
Of 823 patients screened for eligibility, 125 were ineli-
gible due to one or more of the following factors: attend-
ing the clinic for the first time (n = 27); no confirmed
cancer diagnosis (n = 1); non-English speaking (n = 70);
too unwell (n = 6); unable to provide informed consent
(n = 2), unable to complete the survey independently
(n = 7), or other reasons (n = 12). Of the remaining 698
eligible patients, 612 (88%) provided consent.
Of those who consented, 355 completed both the
initial survey and the second survey and were in-
cluded in the analyses. Comparing those who com-
pleted both surveys to those who only completed the
baseline survey, the non-completers were more often
male (57% compared to 45% who completed, p <
0.051) and older (75% over 60 years compared to 46%
for completers, p = 0.002) Of the patient characteris-
tics, the age range reflects cancer incidence with over
half of the participants aged over 60 years, and there
was a good spread across the three treatment centres
(Table 1).
Of the 57 (16.1%; 95% CI 6.8 to 25.4%) patients who
sought a second opinion, the most frequent reasons
given for doing so were the need for reassurance (49.1%)
Table 1 Sample demographic
Variable Characteristic Total
(N = 355)
Gender Male 159 (45%)
Female 196 (55%)
Age category 18–40 21 (6.0%)
41–60 140 (40%)
61+ 190 (54%)
Age mean (SD) 61.13 (11.68)
median (min, max) 62.33 (26.99, 100.07)
Married Married or partner 243 (69%)
Single, divorced, separated or widowed 110 (31%)
Education HS or below 151 (43%)
Vocational training, University or other 199 (57%)
Health insured Yes 163 (46%)
No 189 (54%)
Concession Yes 189 (54%)
No 164 (46%)
Living with With Others 279 (79%)
Alone 74 (21%)






More than one type 98 (28%)
Other 7 (2.0%)
Number of patients at each treatment centre 101 127 (36%)
208 120 (34%)
616 108 (30%)
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and the need to consider the range of treatment options
(41.8%) (Table 2).
Of the 297 (83.6%) participants who did not seek a
second opinion, the main reason was confidence in the
first doctor (88.7%). Only 3.1% patients did not know
that they could ask for a second opinion (Table 3). Oc-
casionally the doctor will initiate the referral for a sec-
ond opinion (Table 3).
A univariable and multivariable logistic regression ana-
lysis to assess association of the age, gender, stage, edu-
cation level and those with health insurance with
seeking a second opinion. Having health insurance was
associated with seeking a second opinion, after adjusting
for age, education, and gender; the odds of seeking a sec-
ond opinion were two times higher for those with health
insurance compared to those without health insurance
(95%CI 1.1 to 3.7; p = 0.02). The other variables were not
associated with seeking a second opinion.
Discussion
Our study found that 16.1% of participants had sought a
second opinion about their cancer treatment. This is be-
tween the rates reported In Australia by Tattersall’s and
Philip’s study [5, 6]. This most likely reflects methodo-
logical differences in that our survey asked participants
if they had ever sought a second opinion in relation to
their cancer treatment; while the Tattersall study [5] ex-
amined second opinions sought at a specific point in
time.
The study findings that the main reasons for cancer
patients seeking second opinions were reassurance and
to seek information to ensure that they had been pre-
sented with all of their options reflect previous studies.
A review of 13 studies revealed that the two most im-
portant topics in seeking second opinions were treat-
ment options and prognosis [7]. In the Australian study
by Tattersall et al., 64 of 77 patients who returned ques-
tionnaires had received new information from their
second opinions [5]. They also felt more confident after
receiving a second opinion, particularly if they had
expressed dissatisfaction with their initial doctor. Like-
wise, a group of prostate cancer patients wanted more
information but also wanted to see whom they regarded
as the best urologist [8]. While losing time was an issue
for not seeking second opinions for up to 18% in other
studies, only 3.4% of patients in our study wanted to
commence treatment as soon as possible [9].
Of 1901 patients consulting medical oncologists early
stage breast cancer patients 9.8% sought a second opin-
ion. In addition to higher education and use of internet
support groups, uncertain results on genomic testing
predicted seeking a second opinion. This may indicate
that demand of r seconds opinions may increase with
the introduction of more complex genomic tests to
guide treatment decisions [10].
The proportion of participants who reported that they
did not know they could ask for a second opinion was
low in our study. Patients know about second opinions
either from their doctors, government agencies or other
information forums or consumer organisations [1, 7, 11].
Many patients also gain extra information from friends,
relatives and the internet [5, 7].. It has been suggested
that patients may feel reassured about their care if they
knew that treatment guidelines existed and that their
case had been discussed by a multidisciplinary team [5,
7]. However two studies found that knowledge that their
treatment plan came from a multidisciplinary team had
no impact on patients’ decision to seek a second opinion
[5, 12].
The rate of dissatisfaction with the doctor giving the
primary opinion was lower in our study (16.4%) than in
multiple other studies where it has been reported by
around 30% of participants [6, 13]. In a study involving
prostate cancer patients, seeking a second opinion was
not associated with accepting definitive treatment [8].
This raises the possibility of patients shopping for
Table 2 Reason for seeking a second opinion (n = 57). Frequencies and percentages with confidence intervals
Reason for second opinion Response Frequency Percent Confidence interval for percentage
Needed reassurance Yes 27 49.1 (21.0, 77.2)
Needed To Consider Options Yes 23 41.8 (15.3, 68.3)
Family and Friends Yes 14 25.5 (0.0, 53.4)
Wasn’t Comfortable with First Dr Yes 9 16.4 (1.8, 30.9)
Didn’t Trust First Dr Yes 8 14.5 (0.0, 60.2)
First Dr. Didn’t Understand My Concerns Yes 5 9.1 (0.0, 22.2)
Didn’t Understand Treatment Choices Yes 4 7.3 (2.4, 12.1)
Consulted A Second Doctor To Get Access To A Clinical Trial Yes 2 3.5 (0.0, 11.6)
Second Opinion In Order To Access Treatment Faster Yes 2 3.5 (0.0, 11.6)
Other/Unclear Yes 3 5.5 (0.0, 16.8)
Recommended by 1st Doctor Yes 2 3.5 (0.0, 18.0)
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opinions that align with their wishes. Dissatisfaction is
often due to communication issues between doctors and
patients [6]. It has been suggested that satisfaction with
a second opinion may involve patient factors where a
changing emotional state over time may make them
readier to hear information as time passes [6].
Trust in the physician was a major reason for pa-
tients not seeking a second opinion [9, 14]. Moreover
some patients saw seeking a second opinion as pos-
sibly affecting the relationship with the clinician who
gave the initial opinion [6, 15]. Many oncologists have
no issues with their patients seeking second opinions
and often associate seeking a second opinion with the
patient having greater information and support needs
[6].
The biggest issue for future studies is whether referral
for a second clinical opinion actually improves quality of
care and clinical outcomes, since, unlike with diagnostic
studies this has been difficult to demonstrate [7, 16].
Some studies have shown doctors second opinions are
influenced by the initial opinion and those giving subse-
quent opinions are certainly aware of the medico-legal
consequences of their consultation [6]. If consultations
are by multi-disciplinary teams and follow evidence
-based guidelines there may be little difference between
treatments, particularly if the major issue for seeking the
second opinion was a communication problem. This
would explain why knowledge of their care had been dis-
cussed by a multidisciplinary team had no impact on pa-
tients’ second opinion seeking.
The limitations of the generalisability of the study
findings include the exclusion of participants who did
not speak English and recruitment from three metropol-
itan hospitals. Recall bias from the participants who were
diagnosed more than 1 year ago may result in a slight
underestimation of the frequency of obtaining a second
opinion.
It would be worth exploring further whether patients
having easier access to evidence-based guidelines may
prove reassuring. That was part of motivation for web-
based wiki guidelines in cancer that could be widely dis-
seminated an easily accessed [17]. Issues to be explored
in future studies of second opinions include collection of
data on whether the second opinion changed the treat-
ment plan proposed by the first consultation. Secondly,
those receiving a second opinion could have their cancer
outcomes compared to a matched group who did not re-
quest a second opinion with cancer outcomes of survival
and progression free survival assessed. There is not a
good economic analysis of the cost benefit of second
opinions. Finally, a longitudinal study of patient and pro-
vider satisfaction would help determine the longer-term
impact of a second opinion. It is also important to ascer-
tain further patient characteristics which may predict
the likelihood of seeking a second opinion.
Conclusions
Our study suggests that a minority of cancer patients
seek a second opinion at some phase during their care.
Most did so for reassurance or to ensure that they had
covered all of the treatment options and only 14.5% be-
cause of discomfort or distrust of their treating doctor.
Few patients reported a lack of awareness of second
opinions. This suggests that second opinions form part
of a patient-centred approach to information provision
about care options. Whether the second opinion im-
proves the quality of care or indeed outcomes has been
difficult to demonstrate.
Abbreviations
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Table 3 Reason for not seeking a second opinion (n = 297). Frequencies and percentages with confidence intervals
Reason for no second opinion Response Frequency Percent Confidence interval for percentage
Confident With First Dr Yes 259 88.7 (77.9, 99.5)
Not Enough Money Yes 73 25.0 (19.5, 30.5)
Didn’t Know Which Dr. To See Yes 12 4.1 (0.0, 8.3)
Wanted to Start Treatment ASAP Yes 10 3.4 (0.0, 9.5)
Didn’t Know I Could Get a Second Opinion Yes 9 3.1 (0.0, 9.6)
Not Enough Time Yes 6 2.1 (0.0, 11.0)
Didn’t Want to Upset Dr Yes 4 1.4 (0.0, 3.0)
Felt Rushed Into Treatment Yes 4 1.4 (0.0, 9.6)
Didn’t Feel It Was Necessary Yes 2 0.7 (0.0, 2.1)
Other Yes 4 1.4 (0.0, 5.5)
Four participants reported ‘other reasons’ including: “I had enough info from my own investigating to make a decision”, “I was overwhelmed with diagnosis when
with doctor;” and “too late, I feel, to start again.” One participant reported that their situation had been discussed at the multidisciplinary team meeting, and so
perceived “I’ve had a lot of Drs. Opinion”
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